Regeneron Pharma (REGN) PT Raised to $868 at Morgan Stanley
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $808.46 +1.31%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on Regeneron Pharma (NASDAQ: REGN) to $868.00 (from $851.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Macquarie Upgrades Inventec Corp (2356:TT) to Neutral
- Fuji Electric Co Ltd (6504:JP) (FELTY) PT Raised to JPY17,500 at Nomura/Instinet
- FP Corp (7947:JP) PT Raised to JPY3,230 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
